Literature DB >> 28106510

A drive in SUVs: From development to disease.

Vinay Kumar Rao1, Ananya Pal1, Reshma Taneja1.   

Abstract

Progression of cells through distinct phases of the cell cycle, and transition into out-of-cycling states, such as terminal differentiation and senescence, is accompanied by specific patterns of gene expression. These cell fate decisions are mediated not only by distinct transcription factors, but also chromatin modifiers that establish heritable epigenetic patterns. Lysine methyltransferases (KMTs) that mediate methylation marks on histone and non-histone proteins are now recognized as important regulators of gene expression in cycling and non-cycling cells. Among these, the SUV39 sub-family of KMTs, which includes SUV39H1, SUV39H2, G9a, GLP, SETDB1, and SETDB2, play a prominent role. In this review, we discuss their biochemical properties, sub-cellular localization and function in cell cycle, differentiation programs, and cellular senescence. We also discuss their aberrant expression in cancers, which exhibit de-regulation of cell cycle and differentiation.

Entities:  

Keywords:  Cancer; cell cycle; chromatin modifiers; differentiation; gene regulation; heterochromatin; histones; methylation

Mesh:

Substances:

Year:  2017        PMID: 28106510      PMCID: PMC5406210          DOI: 10.1080/15592294.2017.1281502

Source DB:  PubMed          Journal:  Epigenetics        ISSN: 1559-2294            Impact factor:   4.528


  110 in total

1.  G9a interacts with Snail and is critical for Snail-mediated E-cadherin repression in human breast cancer.

Authors:  Chenfang Dong; Yadi Wu; Jun Yao; Yifan Wang; Yinhua Yu; Piotr G Rychahou; B Mark Evers; Binhua P Zhou
Journal:  J Clin Invest       Date:  2012-03-12       Impact factor: 14.808

2.  A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.

Authors:  Slimane Ait-Si-Ali; Valentina Guasconi; Lauriane Fritsch; Hakima Yahi; Redha Sekhri; Irina Naguibneva; Philippe Robin; Florence Cabon; Anna Polesskaya; Annick Harel-Bellan
Journal:  EMBO J       Date:  2004-02-05       Impact factor: 11.598

3.  Histone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiation.

Authors:  Asoke K Mal
Journal:  EMBO J       Date:  2006-07-13       Impact factor: 11.598

Review 4.  SET domain proteins modulate chromatin domains in eu- and heterochromatin.

Authors:  T Jenuwein; G Laible; R Dorn; G Reuter
Journal:  Cell Mol Life Sci       Date:  1998-01       Impact factor: 9.261

5.  Stabilization of Suv39H1 by SirT1 is part of oxidative stress response and ensures genome protection.

Authors:  Laia Bosch-Presegué; Helena Raurell-Vila; Anna Marazuela-Duque; Noriko Kane-Goldsmith; Adamo Valle; Jordi Oliver; Lourdes Serrano; Alejandro Vaquero
Journal:  Mol Cell       Date:  2011-04-22       Impact factor: 17.970

6.  DNA damage signaling triggers degradation of histone methyltransferases through APC/C(Cdh1) in senescent cells.

Authors:  Akiko Takahashi; Yoshinori Imai; Kimi Yamakoshi; Shinji Kuninaka; Naoko Ohtani; Shin Yoshimoto; Satoshi Hori; Makoto Tachibana; Emma Anderton; Takashi Takeuchi; Yoichi Shinkai; Gordon Peters; Hideyuki Saya; Eiji Hara
Journal:  Mol Cell       Date:  2011-12-15       Impact factor: 17.970

7.  G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes.

Authors:  Danielle Bittencourt; Dai-Ying Wu; Kwang Won Jeong; Daniel S Gerke; Laurie Herviou; Irina Ianculescu; Rajas Chodankar; Kimberly D Siegmund; Michael R Stallcup
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-14       Impact factor: 11.205

8.  Histone methylation at H3K9: evidence for a restrictive epigenome in schizophrenia.

Authors:  Kayla A Chase; David P Gavin; Alessandro Guidotti; Rajiv P Sharma
Journal:  Schizophr Res       Date:  2013-06-28       Impact factor: 4.939

9.  Rb-mediated heterochromatin formation and silencing of E2F target genes during cellular senescence.

Authors:  Masashi Narita; Sabrina Nũnez; Edith Heard; Masako Narita; Athena W Lin; Stephen A Hearn; David L Spector; Gregory J Hannon; Scott W Lowe
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

10.  Crystal structure of the human SUV39H1 chromodomain and its recognition of histone H3K9me2/3.

Authors:  Tao Wang; Chao Xu; Yanli Liu; Kai Fan; Zhihong Li; Xing Sun; Hui Ouyang; Xuecheng Zhang; Jiahai Zhang; Yanjun Li; Farrell Mackenzie; Jinrong Min; Xiaoming Tu
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

View more
  24 in total

1.  Complex role of SIRT6 in NF-κB pathway regulation.

Authors:  Irene Santos-Barriopedro; Alejandro Vaquero
Journal:  Mol Cell Oncol       Date:  2018-05-24

2.  SETDB1 mediated histone H3 lysine 9 methylation suppresses MLL-fusion target expression and leukemic transformation.

Authors:  James Ropa; Nirmalya Saha; Hsiangyu Hu; Luke F Peterson; Moshe Talpaz; Andrew G Muntean
Journal:  Haematologica       Date:  2019-09-26       Impact factor: 9.941

3.  HP1 maintains protein stability of H3K9 methyltransferases and demethylases.

Authors:  Ryo Maeda; Makoto Tachibana
Journal:  EMBO Rep       Date:  2022-02-15       Impact factor: 8.807

4.  Upregulation of histone-lysine methyltransferases plays a causal role in hexavalent chromium-induced cancer stem cell-like property and cell transformation.

Authors:  Zhishan Wang; Jianjun Wu; Brock Humphries; Kazuya Kondo; Yiguo Jiang; Xianglin Shi; Chengfeng Yang
Journal:  Toxicol Appl Pharmacol       Date:  2018-01-31       Impact factor: 4.219

Review 5.  Insight into the multi-faceted role of the SUV family of H3K9 methyltransferases in carcinogenesis and cancer progression.

Authors:  Nirmalya Saha; Andrew G Muntean
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2020-12-26       Impact factor: 10.680

6.  PAF1 complex interactions with SETDB1 mediate promoter H3K9 methylation and transcriptional repression of Hoxa9 and Meis1 in acute myeloid leukemia.

Authors:  James Ropa; Nirmalya Saha; Zhiling Chen; Justin Serio; Wei Chen; Dattatreya Mellacheruvu; Lili Zhao; Venkatesha Basrur; Alexey I Nesvizhskii; Andrew G Muntean
Journal:  Oncotarget       Date:  2018-04-24

Review 7.  Metabolic regulation of chromatin modifications and gene expression.

Authors:  Juan Manuel Schvartzman; Craig B Thompson; Lydia W S Finley
Journal:  J Cell Biol       Date:  2018-05-14       Impact factor: 10.539

Review 8.  Epigenetic Factors That Control Pericentric Heterochromatin Organization in Mammals.

Authors:  Salvatore Fioriniello; Domenico Marano; Francesca Fiorillo; Maurizio D'Esposito; Floriana Della Ragione
Journal:  Genes (Basel)       Date:  2020-05-28       Impact factor: 4.096

9.  Identification of SUV39H2 as a potential oncogene in lung adenocarcinoma.

Authors:  Yu Zheng; Baihui Li; Jian Wang; Yanjuan Xiong; Kaiyuan Wang; Ying Qi; Houfang Sun; Lei Wu; Lili Yang
Journal:  Clin Epigenetics       Date:  2018-10-22       Impact factor: 6.551

10.  Biological processes and signal transduction pathways regulated by the protein methyltransferase SETD7 and their significance in cancer.

Authors:  Inês de Albuquerque Almeida Batista; Luisa Alejandra Helguero
Journal:  Signal Transduct Target Ther       Date:  2018-07-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.